Skip to content

Tianhong Dai, PhD

Principal Investigator

Dr. Dai is an Associate Professor at Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School. He is a current world leader responsible for launching the new research area of antimicrobial blue light therapy for multidrug-resistant infections.

Dr. Dai’s past research has resulted in over 100 publications in peer-reviewed journals with an h-factor of 55 and >12,000 citations (Google Scholar data), and over 20 invited, plenary and keynote presentations at national and international conferences. In addition, Dr. Dai has been the PI of independent grants from the U.S. National Institutes of Health (R01, R21, and R13), the Department of Defense, Consortia for Improving Medicine w/ Innovation & Technology (CIMIT), and various other funding agencies. Dr. Dai’s professional recognition is also evidenced by his service on the grant review panels (or study sections) at the US National Institutes of Health, Department of Defense, National Science Foundation, Harvard Catalyst, French National Research Agency, Ministry of Education of Singapore, Leibniz Association of Germany, etc. In 2021, Dr. Dai served as a member of the FDA/CBER Laboratory Site Visit Review Team.

Prior Experience

Dr. Dai received his PhD in Mechanical Engineering at China Agricultural University, China and completed his postdoc training at Huazhong University of Science and Technology, China. Prior to coming to US, Dr. Dai was an Associate Professor at the Energy Research Institute, State Development & Reform Commission, China. Dr. Dai then had postdoc trainings at Georgia Institute of Technology, Johns Hopkins University and Rice University.

Academic Credentials

Outside of VIC

Dr. Dai is the Founding Chair of the conference “Photonic Diagnosis, Monitoring, Prevention, and Treatment of Infectious Diseases” at the SPIE Photonics West. He is also the Executive Organizing Committee member of the SPIE Photonics West and the Symposium Chair of the newly established “COVID- 19 Application Track” at the SPIE Photonics West. In 2019 and 2020, Dr. Dai was named SPIE Community Champion by the SPIE for his contributions to the community. In addition, Dr. Dai is the Editor-in-Chief of the journal “Recent Patents on Anti-Infective Drug Discovery” and a Theme Editor of the journal “Advanced Drug Delivery Reviews“. He is also an Editorial Board Member of several peer-reviewed journals, such as the “Journal of Photochemistry and Photobiology”, “Photobiomodulation, Photomedicine, and Laser Surgery”, etc.